Administrative Claims Analysis of Asthma-Related Health Care Utilization for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol as Combination Therapy
Felicia Allen‐Ramey(United States Military Academy), Leona E. Markson, Allan T. Luskin(Dean Health Systems), Don A. Bukstein(Institute for Asthma and Allergy), Shiva G. Sajjan
Cited by 34
Related Papers
Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
|The Journal of Allergy and Clinical Immunology In Practice|2018|277
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Shared decision making for the allergist
|Annals of Allergy Asthma & Immunology|2018|119
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
|The Journal of Allergy and Clinical Immunology In Practice|2020|119
Digital Health Technology in Asthma: A Comprehensive Scoping Review
|The Journal of Allergy and Clinical Immunology In Practice|2021|119